Version 2.77

Part Descriptions

LP150045-5   Sequencing
Sequencing is a method used to determine the sequence of individual genes, larger genetic regions (i.e. clusters of genes or operons), full chromosomes or entire genomes. Historically, most sequencing has been performed using the chain termination method developed by Frederick Sanger in 1977. PMID: 271968 Sequencing technologies have improved dramatically, making them cheaper, faster, and more accurate. Next-generation sequencing (NGS), also known as high-throughput sequencing, deep sequencing, and second-generation sequencing, is a type of technology that uses parallel sequencing of multiple small fragments of DNA to determine sequence. This "high-throughput" technology has increased the speed and amount of DNA sequenced at a significantly reduced cost. PMID: 18576944 Several NGS platforms (ie, sequencing instruments and associated reagents) have been developed. Third-generation sequencing is another methodology currently under development that uses parallel sequencing similar to NGS. In contrast to NGS, third-generation sequencing uses single DNA molecules rather than amplified DNA as a template. PMID: 20858600 Source: Regenstrief LOINC

LP265700-7   GATA2 gene
The GATA2 gene encodes for a hematopoietic transcription factor that is vital for the proliferation and maintenance of hematopoietic stem and progenitor cells. GATA2 deficiency affects a variety of systems, including hematopoietic, immune, lymphatic, vascular, urogenital, and neurological systems. Mutations or deletions in the GATA2 gene are associated with myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), and inherited bone marrow failure disorders (IBMFS). Patients with GATA2-related MDS have also been found to have abnormal karyotypes, most commonly monosomy 7, der(1;7) and trisomy 8. PMID: 28643018 Source: National Center for Biotechnology Information (NCBI) Gene

Fully-Specified Name

Component
GATA2 gene full mutation analysis
Property
Find
Time
Pt
System
Bld/Tiss
Scale
Doc
Method
Sequencing

Additional Names

Short Name
GATA2 gene Full Mut Anl Bld/T Seq
Display Name
GATA2 gene full mutation analysis Sequencing Doc (Bld/Tiss)
Consumer Name Alpha Get Info
GATA2 gene variant analysis, Blood or tissue specimen

Basic Attributes

Class
MOLPATH
Type
Laboratory
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Both

Language Variants Get Info

Tag Language Translation
es-ES Spanish (Spain) Gen GATA2 Análisis de mutación completa:Hallazgo:Punto temporal:Sangre o tejido:Doc:Secuenciación
es-MX Spanish (Mexico) Análisis de mutación completo del gen GATA2:Hallazgo:Punto temporal:Sangre o tejido:Documento:Secuenciación
fr-FR French (France) GATA2 gène analyse complète des mutations:Recherche:Ponctuel:Sang/Tissu:Document:Séquençage
it-IT Italian (Italy) GATA2, gene Analisi di mutazione completa:Osservazione:Pt:Sangue/Tess:Doc:Sequenziamento
Synonyms: Osservazione Patologia molecolare Punto nel tempo (episodio) Sangue Sangue o Tessuto Tessuto & Strisci
nl-NL Dutch (Netherlands) GATA2-gen volledige mutatie-analyse:bevinding:moment:bloed of weefsel:document:sequencing
zh-CN Chinese (China) GATA2 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定
Synonyms: GATA Binding Protein 2 gene;GATA 结合蛋白 2 基因 临床文档型;临床文档;文档;文书;医疗文书;临床医疗文书 全血或组织;血液/组织;血液或组织 分子病理学;分子病理学试验 发现是一个原子型临床观察指标，并不是作为印象的概括陈述。体格检查、病史、系统检查及其他此类观察指标的属性均为发现。它们的标尺对于编码型发现可能是名义型，而对于叙述型文本之中所报告的发现，则可能是叙述型。;发现物;所见;结果;结论 完整突变分析;综合突变分析 序列分析;测序 时刻;随机;随意;瞬间 未作说明的组织;组织;组织 & 涂片 血;血液 遗传基因;遗传因子;吉恩;生物基因

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=95771-2